[1]. S. C. Shea 2006 Improving Medication Adherence Lippincott Williams & Wilkins Philadelphia.

[1]. S. C. Shea 2006 Improving Medication Adherence Lippincott Williams & Wilkins Philadelphia.)| false
• Search Google Scholar
• Export Citation

[2]. L. W. Buckalew R. E. Sallis 1986 Patient compliance and medication perception J. Clin. Psychol. 42 49–53.

[2]. L. W. Buckalew R. E. Sallis 1986 Patient compliance and medication perception J. Clin. Psychol. 42 49–53.)| false
• Search Google Scholar
• Export Citation

[3]. F. Köteles Gy. Bárdos 2009 Expectations of side effects evoked by perceptual characteristics of curatives and their psychological background Mentálhigiéné és Pszichoszomatika 10 47–62.

[3]. F. Köteles Gy. Bárdos 2009 Expectations of side effects evoked by perceptual characteristics of curatives and their psychological background Mentálhigiéné és Pszichoszomatika 10 47–62.)| false
• Search Google Scholar
• Export Citation

[4]. A. J. de Craen P. J. Roos A. L. de Vries J. Keijnen 1996 Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness BMJ 313 1624–1626.

[4]. A. J. de Craen P. J. Roos A. L. de Vries J. Keijnen 1996 Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness BMJ 313 1624–1626.)| false
• Search Google Scholar
• Export Citation

[5]. F. Köteles Gy. Bárdos 2007 Expectations of drug effects based on colour and size of tablets Mentálhigiéné és Pszichoszomatika 8 277–290.

[5]. F. Köteles Gy. Bárdos 2007 Expectations of drug effects based on colour and size of tablets Mentálhigiéné és Pszichoszomatika 8 277–290.)| false
• Search Google Scholar
• Export Citation

[6]. L. W. Buckalew K. E. Coffield 1982 An investigation of drug expectancy as a function of capsule colour, size, and preparation form J. Clin. Psychopharmacol. 2 245–248.

[6]. L. W. Buckalew K. E. Coffield 1982 An investigation of drug expectancy as a function of capsule colour, size, and preparation form J. Clin. Psychopharmacol. 2 245–248.)| false
• Search Google Scholar
• Export Citation

[7]. A. J. Barsky R. Saintfort M. P. Rogers J. Borus 2002 Nonspecific medication side effects and the nocebo phenomenon JAMA 287 622–627.

[7]. A. J. Barsky R. Saintfort M. P. Rogers J. Borus 2002 Nonspecific medication side effects and the nocebo phenomenon JAMA 287 622–627.)| false
• Search Google Scholar
• Export Citation

[8]. R. R. Bootzin E. T. Bailey 2005 Understanding placebo, nocebo, and iatrogenic treatment effects J. Clin. Psychol. 61 871–880.

[8]. R. R. Bootzin E. T. Bailey 2005 Understanding placebo, nocebo, and iatrogenic treatment effects J. Clin. Psychol. 61 871–880.)| false
• Search Google Scholar
• Export Citation

[9]. A. J. Barsky J. D. Goodson R. S. Lane P. D. Cleary 1988 The amplification of somatic symptoms Psychosom. Med. 50 510–519.

[9]. A. J. Barsky J. D. Goodson R. S. Lane P. D. Cleary 1988 The amplification of somatic symptoms Psychosom. Med. 50 510–519.)| false
• Search Google Scholar
• Export Citation

[10]. C. Davis E. Ralevski S. Kennedy C. Neitzert 1995 The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: a study of healthy male and female volunteers J. Clin. Psychopharmacol. 15 347–352.

[10]. C. Davis E. Ralevski S. Kennedy C. Neitzert 1995 The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: a study of healthy male and female volunteers J. Clin. Psychopharmacol. 15 347–352.)| false
• Search Google Scholar
• Export Citation

[11]. A. L. Geers S. G. Helfer K. Kosbab P. Weiland S. J. Landry 2005 Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response J. Psychosom. Res. 58 121–127.

[11]. A. L. Geers S. G. Helfer K. Kosbab P. Weiland S. J. Landry 2005 Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response J. Psychosom. Res. 58 121–127.)| false
• Search Google Scholar
• Export Citation

[12]. F. Köteles Gy. Bárdos 2011 What makes us sicker? An experimental study of non-specific adverse drug effects Clin. Exp. Med. J. 5 203–215.

[12]. F. Köteles Gy. Bárdos 2011 What makes us sicker? An experimental study of non-specific adverse drug effects Clin. Exp. Med. J. 5 203–215.)| false
• Search Google Scholar
• Export Citation

[13]. C. D. Spielberger R. L. Gorsuch R. E. Lushene 1970 Manual for the State-Trait Anxiety Inventory Consulting Psychologists Press Palo Alto, CA.

[13]. C. D. Spielberger R. L. Gorsuch R. E. Lushene 1970 Manual for the State-Trait Anxiety Inventory Consulting Psychologists Press Palo Alto, CA.)| false
• Search Google Scholar
• Export Citation

[14]. K. Kroenke R. L. Spitzer J. B. Williams 2002 The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms Psychosom. Med. 64 258–266.

[14]. K. Kroenke R. L. Spitzer J. B. Williams 2002 The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms Psychosom. Med. 64 258–266.)| false
• Search Google Scholar
• Export Citation

[15]. A. J. Barsky G. Wyshak G. L. Klerman 1990 The Somatosensory Amplification Scale and its relationship to hypochondriasis J. Psychiatr. Res. 24 323–334.

[15]. A. J. Barsky G. Wyshak G. L. Klerman 1990 The Somatosensory Amplification Scale and its relationship to hypochondriasis J. Psychiatr. Res. 24 323–334.)| false
• Search Google Scholar
• Export Citation

[16]. M. F. Scheier C. S. Carver M. W. Bridges 1994 Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the life orientation test J. Pers. Soc. Psychol. 67 1063–1078.

[16]. M. F. Scheier C. S. Carver M. W. Bridges 1994 Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the life orientation test J. Pers. Soc. Psychol. 67 1063–1078.)| false
• Search Google Scholar
• Export Citation